Hong Kong · Delayed Price · Currency is HKD Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of HKD 15.74 billion. The enterprise value is 12.38 billion.
| Market Cap | 15.74B |
| Enterprise Value | 12.38B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.12B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +8.42% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 91.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.43 |
| PB Ratio | 3.03 |
| P/TBV Ratio | 3.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.40 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.13 |
| Interest Coverage | -42.85 |
Financial Efficiency
Return on equity (ROE) is -24.19% and return on invested capital (ROIC) is -15.98%.
| Return on Equity (ROE) | -24.19% |
| Return on Assets (ROA) | -13.36% |
| Return on Invested Capital (ROIC) | -15.98% |
| Return on Capital Employed (ROCE) | -34.51% |
| Weighted Average Cost of Capital (WACC) | 7.86% |
| Revenue Per Employee | 1.99M |
| Profits Per Employee | -782,753 |
| Employee Count | 1,784 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 5.99 |
Taxes
| Income Tax | -11.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.13% in the last 52 weeks. The beta is 0.78, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -52.13% |
| 50-Day Moving Average | 15.42 |
| 200-Day Moving Average | 17.29 |
| Relative Strength Index (RSI) | 52.72 |
| Average Volume (20 Days) | 12,023,391 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.57 |
Income Statement
In the last 12 months, Zai Lab had revenue of HKD 3.55 billion and -1.40 billion in losses. Loss per share was -12.67.
| Revenue | 3.55B |
| Gross Profit | 288.08M |
| Operating Income | -1.90B |
| Pretax Income | -1.41B |
| Net Income | -1.40B |
| EBITDA | -1.78B |
| EBIT | -1.90B |
| Loss Per Share | -12.67 |
Balance Sheet
The company has 5.18 billion in cash and 1.82 billion in debt, with a net cash position of 3.37 billion.
| Cash & Cash Equivalents | 5.18B |
| Total Debt | 1.82B |
| Net Cash | 3.37B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.19B |
| Book Value Per Share | 46.75 |
| Working Capital | 4.33B |
Cash Flow
In the last 12 months, operating cash flow was -791.86 million and capital expenditures -60.85 million, giving a free cash flow of -852.72 million.
| Operating Cash Flow | -791.86M |
| Capital Expenditures | -60.85M |
| Depreciation & Amortization | 121.45M |
| Net Borrowing | 266.22M |
| Free Cash Flow | -852.72M |
| FCF Per Share | n/a |
Margins
Gross margin is 8.11%, with operating and profit margins of -53.50% and -39.29%.
| Gross Margin | 8.11% |
| Operating Margin | -53.50% |
| Pretax Margin | -39.62% |
| Profit Margin | -39.29% |
| EBITDA Margin | -50.08% |
| EBIT Margin | -53.50% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.42% |
| Shareholder Yield | -8.42% |
| Earnings Yield | -8.87% |
| FCF Yield | -5.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Zai Lab is 20.95, which is 45.89% higher than the current price. The consensus rating is "Buy".
| Price Target | 20.95 |
| Price Target Difference | 45.89% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 17.99% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 10.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Zai Lab has an Altman Z-Score of 1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 3 |